Showing 2 posts of 2 posts found.
As the final details of the new GP contract are decided, the pharmaceutical industry is now preparing itself for a …
The new GP contract was supported by a massive 79 per cent of those GPs who voted for it, despite …
Qureight paper argues for fibrosis extent as imaging biomarker in lung disease trials
START and Rome cancer institute partner to expand early-phase trial access in Italy
AbbVie expands Oxford R&D facility with new £120m UK research commitment
MedPharm appoints Jason Mieding as chief operating officer
UKRI backs five hubs developing AI tools for earlier disease detection